February 8, 2025 Week in Review: Trade Wars, Earnings, and Labor Data
February 4, 2025 AI Ventures Soar as Trade Tensions Heat Up – Key Weekly Highlights
Tesla's Shanghai Megapack Factory: A Catalyst for Future Growth
Nvidia: Seizing Long-Term Growth Amid Cost Challenges and AI Momentum
February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024
January 21, 2025 Trading Stocks With AI: A Modern Approach
January 21, 2025 Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025
January 1, 2025 Advanced Charting Tools For Traders
December 21, 2024 Why Is Trading Important?
RenovoRx (RNXT) Stock Forecast for 2025, 2026, 2027. Sell or Buy?
Updated: February 16, 2025 (12:17)
Sector: HealthcareThe share price of RenovoRx, Inc. (RNXT) now
Are you interested in RenovoRx, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the RenovoRx stock price in 2025, 2026, 2027. How much will one RenovoRx share be worth in 2025 - 2027?
When should I take profit in RenovoRx stock? When should I record a loss on RenovoRx stock? What are analysts' forecasts for RenovoRx stock? What is the future of RenovoRx stock? We forecast RenovoRx stock performance using neural networks based on historical data on RenovoRx stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
RenovoRx stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for RenovoRx shares. This happens once a day.
Historical and forecast chart of RenovoRx stock
The chart below shows the historical price of RenovoRx stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the RenovoRx stock price can be found in the table below.
Long-term forecasts by years.
RenovoRx, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for the local treatment of solid tumors. Its therapy platform, RenovoRx, handles the optimizing drug concentration in solid tumors using approved small molecule chemotherapeutics that enable physicians to isolate segments of the vascular anatomy closest to tumors and force chemotherapy across the blood vessel wall to bathe these difficult-to-reach tumors in chemotherapy. The company was founded by Ramtin Agah and Kamran Najmabadi in December 2009 and is headquartered in Los Altos, CA.
RenovoRx daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Feb 18 | 1.01 | 0.95 | 1.06 | 11.79 |
| Feb 19 | 0.97 | 0.92 | 1.06 | 15.88 |
| Feb 20 | 0.88 | 0.81 | 0.94 | 16.03 |
| Feb 21 | 0.90 | 0.84 | 0.93 | 10.76 |
| Feb 22 | 0.85 | 0.80 | 0.93 | 15.43 |
| Feb 23 | 0.94 | 0.88 | 0.96 | 10.02 |
| Feb 24 | 0.90 | 0.85 | 0.96 | 13.55 |
| Feb 25 | 0.90 | 0.87 | 0.96 | 10.43 |
| Feb 26 | 0.93 | 0.89 | 0.95 | 6.49 |
| Feb 27 | 0.97 | 0.94 | 1.06 | 12.93 |
| Feb 28 | 0.96 | 0.88 | 1.01 | 14.69 |
| Mar 01 | 0.99 | 0.95 | 1.07 | 12.54 |
| Mar 02 | 1.04 | 0.97 | 1.10 | 13.22 |
| Mar 03 | 1.15 | 1.04 | 1.25 | 20.55 |
| Mar 04 | 1.17 | 1.13 | 1.26 | 11.16 |
| Mar 05 | 1.24 | 1.18 | 1.34 | 12.73 |
| Mar 06 | 1.33 | 1.28 | 1.43 | 11.31 |
| Mar 07 | 1.48 | 1.40 | 1.61 | 15.32 |
| Mar 08 | 1.40 | 1.31 | 1.51 | 14.74 |
| Mar 09 | 1.33 | 1.30 | 1.39 | 7.29 |
| Mar 10 | 1.39 | 1.31 | 1.50 | 14.83 |
| Mar 11 | 1.25 | 1.19 | 1.33 | 11.99 |
| Mar 12 | 1.33 | 1.27 | 1.43 | 11.89 |
| Mar 13 | 1.36 | 1.24 | 1.43 | 15.26 |
| Mar 14 | 1.37 | 1.27 | 1.43 | 12.43 |
| Mar 15 | 1.34 | 1.24 | 1.46 | 17.74 |
| Mar 16 | 1.19 | 1.11 | 1.24 | 10.98 |
| Mar 17 | 1.22 | 1.15 | 1.30 | 13.17 |
| Mar 18 | 1.23 | 1.16 | 1.29 | 10.80 |
| Mar 19 | 1.18 | 1.11 | 1.24 | 12.01 |
RenovoRx Daily Price Targets
RenovoRx Stock Forecast 02-18-2025.
Forecast target price for 02-18-2025: $1.01.
Negative dynamics for RenovoRx shares will prevail with possible volatility of 10.546%.
Pessimistic target level: 0.95
Optimistic target level: 1.06
RenovoRx Stock Forecast 02-19-2025.
Forecast target price for 02-19-2025: $0.97.
Negative dynamics for RenovoRx shares will prevail with possible volatility of 13.701%.
Pessimistic target level: 0.92
Optimistic target level: 1.06
RenovoRx Stock Forecast 02-20-2025.
Forecast target price for 02-20-2025: $0.88.
Negative dynamics for RenovoRx shares will prevail with possible volatility of 13.819%.
Pessimistic target level: 0.81
Optimistic target level: 0.94
RenovoRx Stock Forecast 02-21-2025.
Forecast target price for 02-21-2025: $0.90.
Positive dynamics for RenovoRx shares will prevail with possible volatility of 9.719%.
Pessimistic target level: 0.84
Optimistic target level: 0.93
RenovoRx Stock Forecast 02-22-2025.
Forecast target price for 02-22-2025: $0.85.
Negative dynamics for RenovoRx shares will prevail with possible volatility of 13.365%.
Pessimistic target level: 0.80
Optimistic target level: 0.93
RenovoRx Stock Forecast 02-23-2025.
Forecast target price for 02-23-2025: $0.94.
Positive dynamics for RenovoRx shares will prevail with possible volatility of 9.109%.
Pessimistic target level: 0.88
Optimistic target level: 0.96
RNXT (RNXT) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Mar. | 0.95 | 0.83 | 1.11 | 24.53 |
| Apr. | 1.08 | 0.92 | 1.15 | 20.22 |
| May. | 1.09 | 0.96 | 1.21 | 20.97 |
| Jun. | 0.99 | 0.92 | 1.08 | 14.96 |
| Jul. | 0.89 | 0.78 | 0.98 | 20.18 |
| Aug. | 1.01 | 0.91 | 1.12 | 18.88 |
| Sep. | 1.14 | 0.98 | 1.31 | 25.35 |
| Oct. | 1.16 | 1.10 | 1.25 | 12.45 |
| Nov. | 1.21 | 1.16 | 1.29 | 9.98 |
| Dec. | 1.19 | 1.08 | 1.27 | 14.93 |
RenovoRx forecast for this year
RenovoRx Stock Prediction for Mar 2025
An downtrend is forecast for this month with an optimal target price of $0.95472. Pessimistic: $0.83. Optimistic: $1.11
RenovoRx Stock Prediction for Apr 2025
An uptrend is forecast for this month with an optimal target price of $1.08074. Pessimistic: $0.92. Optimistic: $1.15
RenovoRx Stock Prediction for May 2025
An uptrend is forecast for this month with an optimal target price of $1.08723. Pessimistic: $0.96. Optimistic: $1.21
RenovoRx Stock Prediction for Jun 2025
An downtrend is forecast for this month with an optimal target price of $0.985028. Pessimistic: $0.92. Optimistic: $1.08
RenovoRx Stock Prediction for Jul 2025
An downtrend is forecast for this month with an optimal target price of $0.890465. Pessimistic: $0.78. Optimistic: $0.98
RenovoRx Stock Prediction for Aug 2025
An uptrend is forecast for this month with an optimal target price of $1.01157. Pessimistic: $0.91. Optimistic: $1.12
RenovoRx Stock Prediction for Sep 2025
An uptrend is forecast for this month with an optimal target price of $1.14105. Pessimistic: $0.98. Optimistic: $1.31
RenovoRx Stock Prediction for Oct 2025
An uptrend is forecast for this month with an optimal target price of $1.16387. Pessimistic: $1.10. Optimistic: $1.25
RenovoRx Stock Prediction for Nov 2025
An uptrend is forecast for this month with an optimal target price of $1.21275. Pessimistic: $1.16. Optimistic: $1.29
RenovoRx Stock Prediction for Dec 2025
An downtrend is forecast for this month with an optimal target price of $1.1885. Pessimistic: $1.08. Optimistic: $1.27
RenovoRx (RNXT) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 1.31 | 1.16 | 1.44 | 19.45 |
| Feb | 1.36 | 1.29 | 1.57 | 17.62 |
| Mar | 1.30 | 1.24 | 1.35 | 8.65 |
| Apr | 1.46 | 1.23 | 1.58 | 22.00 |
| May | 1.32 | 1.23 | 1.41 | 12.90 |
| Jun | 1.47 | 1.33 | 1.64 | 19.03 |
| Jul | 1.55 | 1.34 | 1.62 | 16.92 |
| Aug | 1.58 | 1.51 | 1.81 | 16.52 |
| Sep | 1.45 | 1.31 | 1.67 | 21.70 |
| Oct | 1.56 | 1.49 | 1.74 | 14.05 |
| Nov | 1.40 | 1.28 | 1.51 | 15.58 |
| Dec | 1.49 | 1.29 | 1.57 | 18.18 |
RenovoRx (RNXT) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 1.49 | 1.43 | 1.58 | 9.64 |
| Feb | 1.71 | 1.58 | 1.86 | 14.89 |
| Mar | 1.71 | 1.46 | 1.82 | 19.85 |
| Apr | 2.03 | 1.77 | 2.24 | 21.05 |
| May | 2.39 | 2.16 | 2.76 | 21.49 |
| Jun | 2.09 | 1.85 | 2.24 | 17.35 |
| Jul | 2.00 | 1.88 | 2.16 | 13.31 |
| Aug | 1.62 | 1.52 | 1.71 | 11.17 |
| Sep | 1.41 | 1.20 | 1.54 | 21.88 |
| Oct | 1.47 | 1.27 | 1.68 | 24.39 |
| Nov | 1.46 | 1.33 | 1.66 | 20.07 |
| Dec | 1.71 | 1.57 | 1.98 | 20.69 |
RenovoRx information and performance
333 W. SANTA CLARA STREET, SUITE 900, SAN JOSE, CA, US
Market capitalization of the RenovoRx, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of RNXT shares in the company outstanding by the market price of one share.
EBITDA of RenovoRx is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
FAQ (Frequently Asked Questions about RenovoRx Stock)
Should I Buy RenovoRx Shares in 2025 year?
Does RenovoRx pay dividends?
Which economic sector do RenovoRx's shares belong to?
Which other securities belong to the same sector as RenovoRx's shares?
